New Technologies for Gene Targeting + Gene Correction with David Segal, PhD

In this episode, host Lynnea Olivarez talks with David Segal, PhD, an abstract session co-chair at the ASGCT Annual Meeting. Dr. Segal discusses new technologies that he says have moved from academia to industry, and, hopefully soon, to rare disease patients.

Miss a session? Catch it on demand on the virtual platform for 30 days following the conclusion of the meeting!

Show your support for ASGCT!: https://asgct.org/membership/donate

See omnystudio.com/listener for privacy information.